高等学校化学学报 ›› 2000, Vol. 21 ›› Issue (S1): 512.
• Synthetic Sciences • 上一篇 下一篇
LU Jun1, LI Wuan-Hua2, BAI Yin-Juan1, Ma Huai-Rang1
LU Jun1, LI Wuan-Hua2, BAI Yin-Juan1, Ma Huai-Rang1
摘要:
In the past decade,4-aryl-3,4-dihydropyrimidine derivatives have exhibited important pharmacological properties, e.g. as the integral backbones of several calcium channel blockers, antihypertensive agents, alpha-1a-antagonists, and neuropeptide Y (NPY) antagonists[1]. Several lead compounds were developed that are equal in potency and duration of antihypertensive activity to classical and second-generation dihydropyridine drugs[2].
TrendMD: